AIM
ISEE

Alambic Investment Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Alambic Investment Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-83,629
Closed -$228K – 390
2018
Q2 		$228K Sell
83,629
-41,411
-33% -$114K 0.06% 298
2018
Q1 		$343K Buy
125,040
+57,540
+85% +$167K 0.05% 362
2017
Q4 		$211K Buy
+67,500
New +$190K 0.03% 407
2017
Q1 		– Sell
-10,000
Closed -$48K – 689
2016
Q4 		$48K Buy
+10,000
New +$297K 0.01% 554

Other funds holding ISEE

D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Alambic Investment Management's ISEE Position: Q3 2018 in Review

Alambic Investment Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2018, closing a stake of 83,629 shares — an estimated $228K sold.

Alambic Investment Management first reported a position in ISEE in Q4 2016 and held it in 4 quarters. The position peaked at $343K in Q1 2018. 68 funds tracked by Wall St. Rank hold ISEE as of Q3 2018.

  • Alambic Investment Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Alambic Investment Management sold 83,629 IVERIC bio, Inc. Common Stock shares in Q3 2018, an estimated $228K.
  • Alambic Investment Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and held it in 4 quarters.
  • Alambic Investment Management's IVERIC bio, Inc. Common Stock position peaked at $343K in Q1 2018.
  • 68 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2018.

Based on Alambic Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.